Vickers Vantage Corp. I
Status: Deal Closed
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $138.00M |
|---|---|
| IPO Date | Jan 7, 2021 |
| CEO | Jeffrey Chi |
| Left Lead | Maxim |
| IPO Cash in Trust | 101.0% |
| SPAC Tenor | 12 + 3 + 3 + 1 + 1 + 1 + 1 |
| IPO Sector |
General
Not specified |
| IPO Geography | Global |
| Target Company | Scilex |
| Deal Announced | Mar 18, 2022 |
| Deal Size, $M | TBD |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Nov 9, 2022 |
| Amendment Vote | Jun 30, 2022 |
| Closing Date | Nov 10, 2022 |
Formerly VCKA
SCLX
SCLXW
| Price | $0.56 |
|---|---|
| Last closing price | $0.56 |
| H/L, today | $0.56 / $0.58 |
| H/L, 52-week | $1.21 / $16.90 |
| Volume, today | 344,501 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Vickers Vantage Corp. I:
- Structure and cap table
- 6 directors & officers
- 41 filings and events
- 2 underwriters
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Jeffrey Chi | 52 | Chairman and CEO |
| Chris Ho | 33 | CFO and Director |
| Pei Wei Woo | 44 | Director |
| Suneel Kaji | 51 | Director |
| Steve Myint | 62 | Director |
| Dr. Finian Tan | Advisor |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Maxim | BR | 9,500,000 | units |
| B. Riley FBR | 2,500,000 | ||
| 12,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.